Reform Tracks Diverge as Schedule III Lands — April 2026

Access the full version of this brief with detailed access to the complete recap of the last month, as well as a curated database of market insights and regulation updates. April 2026 saw global cannabis splitting into two reform tracks running in opposite directions. The United States moved medical cannabis to Schedule III, unlocking §280E relief across […]
Global Industry Outpaces Its Regulatory Frameworks — March 2026

Access the full version of this brief with detailed access to the complete recap of the last month, as well as a curated database of market insights and regulation updates. March delivered the clearest evidence yet that the global cannabis industry is maturing faster than the regulatory frameworks governing it. Record earnings seasons in Canada and Germany […]
Canada Ships 276 Tonnes of Medical Cannabis in 2025 — but Growth Signals Are Softening

276 tonnes of medical cannabis flower. C$643 million in export value. Roughly three-quarters of the world’s legal medical supply. Canada’s 2025 export data does not merely extend a growth trend — it redefines the country’s position in the global cannabis trade. In a single year, volumes more than doubled, a single regulatory event in Europe […]
Consolidation Wave Reshapes Global Cannabis — February 2026

Access the full version of this brief with detailed access to the complete recap of over 300 global updates in the last month, as well as a curated database of +7,000 regulation updates, market reports and science papers. February 2026 was defined by cross-border consolidation on an unprecedented scale. Organigram acquired Sanity Group for €227M — Europe’s largest cannabis deal — […]
Germany Imports 201 Tonnes of Medical Cannabis in 2025 and Crosses €1 Billion in Sales

Germany’s pharmacy sell-out market surpassed €1 billion for the first time in 2025, with imports reaching a record 201.1 tonnes (+176% YoY) — making it the largest regulated medical cannabis market globally. This data brief examines the supply chain diversification that accompanied that growth, the regulatory and pricing pressures now reshaping the operator landscape, the […]
Commercial Highs Collide with Compliance Friction — January 2026

Access the full version of this brief with detailed access to the complete recap of over 300 global updates from January 2026, as well as a database of +6,500 regulation updates, market reports and science papers. January 2026 marked a month in which volumes hit new highs while the rules governing them lagged behind. Israel broke trade records with 30.5 […]
Czechia’s medical cannabis programme gains momentum as GP reform widens access

Czechia’s medical cannabis programme grew 46% in 2025—the strongest year since 2021. Full-year SÚKL data confirms the GP reform partially worked: prescribing doctors rose 28% to 305, flower grew 35% (233 → 314 kg), and the extract market more than doubled (30 → 76 kg). Domestic EU-GMP producers now anchor supply, while Czech infrastructure increasingly […]
Historic regulatory pivots meet market caution — December 2025

Thank you for being a Cannamonitor subscriber. You have full access to this brief—over 300 December updates across 45+ markets—plus our complete searchable database of 7,000+ regulation, market and science sources: in the Insights section you’ll get access as well to the M&A Tracker mentioned below. December 2025 delivered the most significant US federal cannabis policy shift […]
Hemp Under Siege, Telemedicine Squeezed — November 2025 Brief

Hemp and CBD restrictions reshape access and redraw the global cannabis geoeconomy
Legalisation Momentum Meets Regulatory Headwinds — October 2025 Brief

Access the database with +5,000 regulation updates, market reports and science papers on the international cannabis market. October 2025 highlighted a decisive shift toward regulatory expansion across the global cannabis landscape. Import quotas rose, hospital and pharmacy access widened, and several countries advanced long-awaited legal frameworks — signalling renewed political momentum. Yet these openings coexist with […]
